Fulgent Genetics Crecimiento futuro
Future controles de criterios 0/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Fulgent Genetics de 44.3% y 7% por año respectivamente. Se prevé que el BPA crezca en un 47.3% al año. Se espera que la rentabilidad financiera sea de -2.8% en 3 años.
Información clave
44.3%
Tasa de crecimiento de los beneficios
47.3%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 15.9% |
| Tasa de crecimiento de los ingresos | 7.0% |
| Rentabilidad financiera futura | -2.8% |
| Cobertura de analistas | Low |
| Última actualización | 06 Mar 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Are Investors Undervaluing Fulgent Genetics, Inc. (NASDAQ:FLGT) By 32%?
Mar 01
Fulgent Genetics: Buy Growth Ahead Below Liquidation Value
Feb 21Subdued Growth No Barrier To Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Price
Jan 17Is Fulgent Genetics (NASDAQ:FLGT) Using Debt Sensibly?
Dec 14Fulgent Genetics (NASDAQ:FLGT) Has Debt But No Earnings; Should You Worry?
Aug 09Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report
May 09Fulgent Genetics (NASDAQ:FLGT) Is Looking To Continue Growing Its Returns On Capital
Apr 19Why We Like The Returns At Fulgent Genetics (NASDAQ:FLGT)
Jan 15Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet?
Dec 28What Does The Future Hold For Fulgent Genetics, Inc. (NASDAQ:FLGT)? These Analysts Have Been Cutting Their Estimates
Nov 16Why Fulgent Genetics, Inc. (NASDAQ:FLGT) Could Be Worth Watching
Oct 27Wait For Fulgent Genetics To Grow Up
Oct 13We Like Fulgent Genetics' (NASDAQ:FLGT) Returns And Here's How They're Trending
Sep 19Fulgent Genetics (NASDAQ:FLGT) Seems To Use Debt Rather Sparingly
Sep 05Fulgent Genetics: Poised To Survive Its Post-Covid Hangover
Jul 26Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Low P/E No Reason For Excitement
Jul 21Fulgent Genetics (NASDAQ:FLGT) Is Investing Its Capital With Increasing Efficiency
Jun 04Fulgent Is Putting Its Cash Bonanza To Work
May 15These 4 Measures Indicate That Fulgent Genetics (NASDAQ:FLGT) Is Using Debt Safely
May 04Fulgent Genetics: Now The Going Could Get Much Tougher
Apr 10Fulgent Genetics: COVID Bolstered The Underlying Business
Mar 17Fulgent Genetics: Somewhat Disappoints With A Marked Slowdown In Its NGS Business
Feb 27Fulgent Genetics Stock: 35% Off Its Recent Highs - It Is Now A Buy
Feb 09Fulgent Genetics: Sell Volatility
Jan 26Fulgent Genetics (NASDAQ:FLGT) Has A Rock Solid Balance Sheet
Jan 25Fulgent Genetics: Improving Outlook, But Shares Aren't Quite A Buy
Jan 09Fulgent Genetics: Undervalued, High Growth, And A COVID Hedge To Boot
Dec 20I Ran A Stock Scan For Earnings Growth And Fulgent Genetics (NASDAQ:FLGT) Passed With Ease
Dec 14Fulgent: Now Cheap Enough
Dec 06Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 351 | -57 | N/A | N/A | 2 |
| 12/31/2025 | 322 | -58 | N/A | N/A | 3 |
| 12/31/2024 | 279 | -69 | N/A | N/A | 3 |
| 12/31/2023 | 289 | -168 | 5 | 27 | N/A |
| 9/30/2023 | 286 | -64 | 21 | 45 | N/A |
| 6/30/2023 | 307 | -49 | 31 | 56 | N/A |
| 3/31/2023 | 365 | -26 | 42 | 57 | N/A |
| 12/31/2022 | 619 | 143 | 235 | 254 | N/A |
| 9/30/2022 | 803 | 272 | 277 | 297 | N/A |
| 6/30/2022 | 925 | 392 | 411 | 429 | N/A |
| 3/31/2022 | 953 | 461 | 476 | 494 | N/A |
| 12/31/2021 | 993 | 507 | 515 | 539 | N/A |
| 9/30/2021 | 1,036 | 569 | 554 | 596 | N/A |
| 6/30/2021 | 910 | 493 | 405 | 453 | N/A |
| 3/31/2021 | 773 | 417 | 327 | 372 | N/A |
| 12/31/2020 | 422 | 214 | 105 | 141 | N/A |
| 9/30/2020 | 135 | 48 | -6 | 6 | N/A |
| 6/30/2020 | 44 | 3 | -1 | 1 | N/A |
| 3/31/2020 | 35 | 0 | 4 | 6 | N/A |
| 12/31/2019 | 33 | 0 | 4 | 6 | N/A |
| 9/30/2019 | 30 | -2 | 6 | 6 | N/A |
| 6/30/2019 | 25 | -4 | 1 | 2 | N/A |
| 3/31/2019 | 22 | -6 | 0 | 2 | N/A |
| 12/31/2018 | 21 | -6 | -4 | -1 | N/A |
| 9/30/2018 | 20 | -5 | -7 | -3 | N/A |
| 6/30/2018 | 19 | -6 | -8 | -2 | N/A |
| 3/31/2018 | 18 | -5 | -8 | -1 | N/A |
| 12/31/2017 | 19 | -3 | -4 | 1 | N/A |
| 9/30/2017 | 20 | 0 | N/A | 4 | N/A |
| 6/30/2017 | 21 | -5 | N/A | 4 | N/A |
| 3/31/2017 | 20 | -13 | N/A | 5 | N/A |
| 12/31/2016 | 18 | -14 | N/A | 4 | N/A |
| 9/30/2016 | 15 | -22 | N/A | 3 | N/A |
| 6/30/2016 | 13 | -15 | N/A | 2 | N/A |
| 3/31/2016 | 11 | -6 | N/A | 0 | N/A |
| 12/31/2015 | 10 | -5 | N/A | -1 | N/A |
| 12/31/2014 | 1 | -1 | N/A | -4 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que FLGT siga sin ser rentable en los próximos 3 años.
Beneficios vs. Mercado: Se prevé que FLGT siga sin ser rentable en los próximos 3 años.
Beneficios de alto crecimiento: Se prevé que FLGT siga sin ser rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (7% al año) de FLGT crezcan más despacio que el mercado de US (8.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 7% al año) de FLGT crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: FLGT se prevé que no sea rentable en 3 años.